Medicine safety alert - ranitidine

Withdrawal and Medicines Alerts for Ranitidine Related Products Zantac®, used to treat conditions such as acid reflux in children, has been recalled by its manufacturer because of concerns that it may contain low levels of NDMA.

This is a precautionary measure while the Medicines Health and Regulatory Agency (MHRA) assesses the situation.

This situation is now becoming more generic with additional alerts for (Teva) Ratiopharm Gmbh, Ranitidine Effervescent Tablets 150mg and 300mg. Advice to members is to be aware of these withdrawals and consider de-prescribing or switching after a medication review.